Tools to elevate cardiovascular research have gained ground as the life science instrumentation market continues to expand broadly.
Demand for sophisticated physiological research tools is accelerating worldwide, driven by growth across the life science instrumentation sector. According to MarketsandMarkets, the global life science instrumentation market was valued at USD 59.9 billion (approximately NZD 101.8 billion) in 2024 and is forecast to reach USD 92.5 billion (approximately NZD 157.3 billion) by 2031, growing at a compound annual growth rate of 6.5 percent. This expansion is prompting laboratories and research institutions to invest in more capable, integrated data acquisition platforms that can support complex experimental protocols.
Cardiovascular physiology represents one of the most technically demanding areas within this growth landscape. Researchers working with advanced haemodynamic measurements - such as those who study PV loops to assess ventricular function and cardiac performance - require hardware and software capable of capturing high-fidelity signals in real time. The ability to integrate multiple data streams and customise analysis workflows has become increasingly critical for principal investigators managing complex in vivo and in vitro cardiovascular studies.
The broader cardiac monitoring segment is also expanding rapidly. MarketsandMarkets (Cardiac Monitoring) reports the global cardiac monitoring and cardiac rhythm management devices market reached USD 21.3 billion (approximately NZD 36.2 billion) in 2024, with projections to grow to USD 26.4 billion (approximately NZD 44.9 billion) by 2029. For researchers and educators standardising protocols across multi-site studies or teaching programmes, reliable resources such as a comprehensive 12 lead ECG placement guide are essential for ensuring data quality and consistency across recordings.
Providers such as ADInstruments have expanded their offerings to meet this demand, supplying integrated platforms - including PowerLab hardware and LabChart software - that support cardiovascular, respiratory, and neuroscience research alongside digital teaching tools for medical and nursing education. Founded in New Zealand and operating globally, the company is positioned to serve both research-intensive laboratories and large-scale undergraduate teaching programmes, navigating the increasing complexity of modern physiological science.
More news here.
